Leadership Team

Dodi has more than 16 years of experience in Pharmaceutical Operations in global, big-pharma companies. Dodi is a business-oriented operations leader with a balanced blend of manufacturing, operations, supply chain, and operational excellence who helps pharmaceutical manufacturing organizations to meet their goals through comprehensive optimization processes directly contributing to the bottom line.

She has developed and successfully executed quality and safety cultural changes, improved employee satisfaction and enhanced organizational mindset changes while focusing on achievements.

Her experience also includes providing daily leadership on all aspects of operation, including EH&S, Project Management, Customer Satisfaction, QA, Engineering, MS&T, HR, Finance, and Maintenance. Dodi holds a bachelor’s degree in chemical engineering and a master’s degree in Environmental Engineering

Patrick Lim is a Finance leader with over 30 years of experience in the biotech, life science, and mining industries in both public and private companies. He has held Vice President, Finance roles in the healthcare sector in Medicago Inc., Evolve Biologics, and MDS Inc. (LifeLabs, Nordion, Sciex). His experience in clinical research, commercial manufacturing, new facility construction, strategic business opportunities, financial planning and reporting, global controllership, and ERP systems design and implementation are key for AtomVie.

He has a track record of consistently delivering on operational and strategic initiatives, producing accurate and timely results, and leading high performing finance teams.

Patrick is a Chartered Professional Accountant and has the Certified Information Technology Professional (CITP) designation with the American Institute of CPAs. He also holds a Bachelor of Commerce Degree from the University of British Columbia.

Rezwan Ashique has transitioned into AtomVie as the Vice President of Operations from the same role at CPDC.  Mr. Ashique joined CPDC in 2013 and held several progressive roles over the past 9+ years.  As the Head of the Operations, he oversees the process development/validation programs, routine manufacturing and overall supply chain at AtomVie.  Prior to joining CPDC, he led the establishment of the PERs Facility of Lantheus Medical Imaging in Mississauga, Ontario. Mr. Ashique holds an Hon. B.Sc. in Chemistry with a minor in Economics and an M.Sc. in Radiochemistry.  He has over 20 years of extensive experience in development, validation and routine manufacturing of sterile and ready-to-use diagnostic and therapeutic radiopharmaceuticals.

Ghadeer Shubassi transitioned into AtomVie’s Leadership Team as the Director of Business Development from the same role at CPDC. Ghadeer leads a Business Development team that is focused on client acquisitions, partnerships, marketing and communications. She joined CPDC on November 2019 as the Manager of Business Development and was promoted to the Associate Director in 2022. Prior to CPDC, Ghadeer gained experiences in commercialization of antibodies and biologics (at former CCAB: The Centre for The Commercialization of Antibodies & Biologics) as well as cell and gene therapies (at CCRM: Centre for Commercialization of Regenerative Medicine). She has 15+ years of professional experience in life sciences, with a focus on anti-cancer drugs. Ghadeer holds a PhD in Biochemistry from the University of Toronto followed by a post-doctoral fellowship in cancer signaling pathways at the FIRC Institute of Molecular Oncology; IFOM (Milan, Italy).

Fina brings expertise in quality systems management, regulatory compliance, and GMP operations gained through more than 20 years of experience in pharmaceutical and radiopharmaceutical industries. Fina has a Bachelor and Master of Pharmaceutical Science from the University of Barcelona, and a Master of Business Administration from ESADE Business School.

Her experience includes an executive quality leadership role at CPDC, where she led quality operations, supported clinical radiopharmaceutical products, successfully prepared the site for FDA re-inspection, and drove Health Canada inspections resulting in compliant ratings. She has provided strategic quality consulting, remediation, validation, and inspection readiness support to various pharmaceutical organizations.

Fina leads AtomVie's quality and compliance functions, ensuring compliance with cGMP regulations and regulatory requirements. She oversee's quality systems, audits, inspections, and continuous improvement initiatives, while providing leadership to the Quality team and supporting efficient manufacturing operations. She also play's a key role in preparing AtomVie for future growth by supporting new facility readiness, regulatory compliance, and transition to commercial manufacturing.

Angela Lauretani has transitioned to AtomVie’s Leadership Team as the Senior Director of Finance and Administration from CPDC. Angela began working for CPDC as the Finance Controller in 2015 and transitioned to the Leadership team in 2018. In her current role, Ms. Lauretani is responsible for the Finance operations of AtomVie, including budgeting and commercialization efforts. She also oversees the Corporate Governance of the organization and the IT & Administration departments.

Angela has over 15 years of experience in financial management, previously employed by a publicly traded company (NYSE) for 10 years and began her professional career in public accounting with KPMG, where she obtained her Chartered Accountant, CA, CPA designation. Angela holds an Honours Bachelor of Commerce from McMaster University.

Constantinos Economou is the Senior Director of Engineering and Head of the new Facility Delivery Team at AtomVie Global Radiopharma (AtomVie). He currently oversees the construction, setup, and commissioning of AtomVie’s state-of-the-art 72,300-square-foot (6,700 m²) radiopharmaceutical CDMO facility.

Constantinos began his radiopharmaceutical career in 2010 at the Centre for Probe Development and Commercialization (CPDC), where he held several leadership roles across Engineering and Manufacturing Operations. Over his tenure at CPDC and AtomVie, he has played a key role in the renovation and construction of five radiopharmaceutical sites.

With more than 25 years of engineering experience, Constantinos brings extensive expertise in GMP facility design and construction, commissioning, radiopharmaceutical operations, and automation systems.

Patrick Ruddock joined AtomVie’s parent company, CPDC, in 2011 as a Regulatory Affairs Associate and moved into his current role as Director, Regulatory and Clinical in 2022. Currently Patrick is responsible for all regulatory and clinical research activities at AtomVie. This includes investigational and commercial product submissions for AtomVie and its clients, interactions with regulators, establishment licensing, clinical trial management, pharmacovigilance, regulatory strategy and risk assessment.

Patrick has over 14 years’ experience with both CMC and clinical aspects of regulatory affairs, including working with radiopharmaceuticals, biologics and medical devices. He holds a M.Sc. (Microbiology) from the University of Ottawa and a post-graduate certificate in Regulatory Affairs from Humber College.

Jake Hasan, is an HR executive with over 20 years of business and HR experience in multiple industries including life sciences, manufacturing, consumer goods, and pulp and paper, with passion for aligning the people strategies with the business goals, enabling growth and success by engaging, motivating, and developing the most critical asset –People-.

Jake is a member of HRPA Ontario as a Certified Human Resources Executive (CHRE), holds a degree in industrial engineering, and diplomas in various HR topics. He is a dedicated father who enjoys travel and helping others.